Abbott Laboratories faced with anti-Aids drug dilemma
Monday 04 July 2005
The Latin American emerging economy served notice last month it would use powers under global trade rules to break Abbott's patent and make a generic copy of the Kaletra pill to cut the costs of its fight against the disease.
Abbott issued a vitriolic response last week, accusing Brazilian politicians of putting "short-term manoeuvring" over the interests of its own people.
It has to decide within 10 days of the request whether to cut its prices or lose its business to a Brazilian manufacturer that will make them for half the $1.17 Abbott charges. The deadline is understood to fall on Wednesday.
The spat is a test case that will have huge implications for both the global fight against HIV/Aids and the biotech industry in the UK, US and Europe.
It would be the first time a country has invoked its rights under concessions won during World Trade Organisation negotiations that allows governments to make cheap copies of drugs needed to tackle local health emergencies.
The Brazilian government says that as many as 600,000 Brazilians carry the virus and forecasts that by 2008 it will be spending $520m (£290m) a year on a cocktail of drugs including Kaletra.
"Brazil is concerned about doing a good job of treating those Brazilians who need it, with the proper medication," said Humberto Costa, the country's health minister.
Health and poverty groups fully support Brazil's action. Jim Kim, director of the department of HIV/Aids at the World Health Organisation in Geneva, said: "The Brazilian government is perfectly within its rights to suspend the patent of Kaletra ... so as to develop it at more accessible prices."
Oxfam said buying Aids drugs from Abbott and its fellow US giants Merck and Gilead Sciences used up 67 per cent of the country's budget for tackling the disease.
In its statement, Abbott said that as the world's ninth-largest economy, Brazil's demand for the same rights as the poorest countries was "against the spirit" of the agreement. It said: "Such a mis-step puts short-term manoeuvring ahead of the access to new and improved treatments."
It said compulsory licensing would have "significant negative consequences" for the development of future treatments for a range of diseases.
Britain to take more refugees as Cameron bows to pressure after more than 250,000 back our campaign
Senior British politicians tell David Cameron: When dead children are being washed up on beaches – it's time to act
Jeremy Corbyn calls Osama bin Laden's killing a 'tragedy' - but was it taken out of context?
If these extraordinarily powerful images of a dead Syrian child washed up on a beach don't change Europe's attitude to refugees, what will?
If you're not already angry about the refugee crisis, here's a history lesson to remind you why you really should be
Make your voice heard: Sign The Independent's petition to welcome refugees
- 1 What marriage would look like if we actually followed the Bible
- 2 President Obama leaves touching comment on Humans of New York photo from Iran
- 3 If these extraordinarily powerful images of a dead Syrian child washed up on a beach don't change Europe's attitude to refugees, what will?
- 4 The Chinese city where men have 'three girlfriends because there are so many women'
- 5 'Heartbreaking' Syria orphan photo wasn't taken in Syria and not of orphan